Transforming growth factor-β inhibits coxsackievirus-mediated autoimmune myocarditis

Viral Immunology

Volumn 19, Issue 4, 2006, Pages 722-733

  Horwitz, Marc S ^a   Knudsen, Maria ^a   Ilic, Alex ^b   Fine, Cody ^b   Sarvetnick, Nora ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIE VIRUS B; FEMALE; HEART FAILURE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; TRANSGENIC MOUSE; VIRUS MYOCARDITIS; VIRUS REPLICATION;

COXSACKIEVIRUS; HUMAN ENTEROVIRUS B; MUS; MUS MUSCULUS;

ANIMALS; AUTOIMMUNE DISEASES; COXSACKIEVIRUS INFECTIONS; DOWN-REGULATION; ENTEROVIRUS; FEMALE; INSULIN-SECRETING CELLS; MACROPHAGES; MALE; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; MODELS, ANIMAL; MYOCARDITIS; PANCREAS; TRANSFORMING GROWTH FACTOR BETA; VIRUS REPLICATION;

EID: 33846083900     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.722     Document Type: Article

References (61)

1. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox M, Schofield BH, Hill SL, and Rose NR: Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 2001;159:193-203.
2. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, and Wahl SM: Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β. J Exp Med 1990;171:231-247.
3. + human thymocytes. J Exp Med 2002;196: 379-387.
4. Ashcroft GS: Bidirectional regulation of macrophage function by TGF-β. Microbes Infect 1999;1:1275-1282.
5. 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. J Immunol 1992;148: 3912-3919.
6. Bogdan C, Paik J, Vodovotz Y, and Nathan C: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 1992;267:23301-23308.
7. Cazac BB, and Roes J: TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 2000;13:443-451.
8. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
9. Choi P, and Reiser H: IL-4: role in disease and regulation of production. Clin Exp Immunol 1998;113:317-319.
10. Cunningham MW: Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am J Pathol 2001;159:5-12.
11. Deenick E, Hasbold J, and Hodgkin P: Switching to IgG3, IgG2b, and IgA is division linked and independent, revealing a stochastic framework for describing differentiation. J Immunol 1999;163:4707-4714.
12. Dong Y, Tang L, Letterio JJ, and Benveniste EN: The Smad3 protein is involved in TGF-β inhibition of class II transactivator and class II MHC expression. J Immunol 2001;167:311-319.
13. Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, Schacker T, Picker LJ, Watkins DI, Lifson JD, Reilly C, Carlis J, and Haase AT: Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006;193:703-712.
14. Fairweather D, Frisancho-Kiss S, and Rose NR: Viruses as adjuvants for autoimmunity: Evidence from coxsackievirus-induced myocarditis. Rev Med Virol 2005;15: 17-27.
15. Fairweather D, Kaya Z, Shellam GR, Lawson CM, and Rose NR: From infection to autoimmunity. J Autoimmunity 2001;16:175-186.
16. Falcone M, and Sarvetnick N: Cytokines that regulate autoimmune responses. Curr Opin Immunol 1999;11: 670-676.
17. 1 prevents the noncognate maturation 5f human dendritic Langerhans cells. J Immunol 1999;162:4567-4575.
18. Goerdt S, and Orfanos CE: Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999;10:137-142.
19. Holder MJ, Knox K, and Gordon J: Factors modifying survival pathways of germinal center B cells: Glucocorticoids and transforming growth factor-β, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis. Eur J Immunol 1992;22:2725-2728.
20. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, and Sarvetnick N: Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 2000;6:693-697.
21. Huber SA, Gauntt CJ, and Sakkinen P: Enteroviruses and myocarditis: Viral pathogenesis through replication, cytokine induction and immunopathogenicity. Adv Virus Res 1998;51:35-80.
22. Imai K, Takeshita A, and Hanazawa S: Transforming growth factor-β inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 5 and CD14 receptor expression. Infect Immun 2000;68:2418-2423.
23. Kaya Z, Afanasyeva M, Wang Y, Dohmen KM, Schlichting J, Tretter T, Fairweather D, Holers VM, and Rose NR: Contribution of the innate immune system to autoimmune myocarditis: A role for complement. Nat Immunol 2001;2:739-745.
24. Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, and Rose NR: Cutting edge: A critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol 2002;168:1552-1556.
25. Kee BL, Rivera RR, and Murre C: Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat Immunol 2001;2:242-247.
26. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, and Fauci AS: Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986;137:3855-3860.
27. 1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 1998;8:601-613.
28. + T cell responses. Nat Med 2001;7:206-214.
29. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002;169: 4712-4716.
30. Kuklin NA, Daheshia M, Chun S, and Rouse BT: Immunomodulation by mucosal gene transfer using TGF-β DNA. J Clin Invest 1998;102:438-444.
31. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, and Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-240.
32. 1. Am J Pathol 1995;147:42-52.
33. 1. Am J Pathol 1995;147:42-52.
34. Letterio JJ, and Roberts AB: Regulation of immune responses by TGF-β. Annu Rev Immunol 1998;16:137-161.
35. 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 1995;154:1634-1643.
36. Lutgens E, and Daemen MJ: Transforming growth factor-β: A local or systemic mediator of plaque stability. Circ Res 2001;89:853.
37. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R, Fradelizi D, and Tedgui A: Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001;89:930-934.
38. Masurier C, Pioche-Durieu C, Colombo BM, Lacave R, Lemoine FM, Klatzmann D, and Guigon M: Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: Implications for antitumoral cell therapy. Immunology 1999;96:569-577.
39. Mueller R, Bradley LM, Krahl T, and Sarvetnick N: Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity 1997;7:411-418.
40. Mueller R, Krahl T, and Sarvetnick N: Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic mice. J Exp Med 1996;184:1093-1100.
41. Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, and Arditi M: Transforming growth factor-β differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem 2005;280:5491-5495.
42. + regulatory T cell activity in both humans and mice. J Immunol 2004;172:834-842.
43. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med 2001;194:629-644.
44. + regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci USA 2004;101: 4572-4577.
45. Petit-Koskas E, Genot E, Lawrence D, and Kolb JP: Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-β. Eur J Immunol 1988;18:111-116.
46. Ray S, Broor SL, Vaishnav Y, Sarkar C, Girish R, Dar L, Seth P, and Broor S: Transforming growth factor β in hepatitis C virus infection: In vivo and in vitro findings. J Gastroenterol Hepatol 2003;18:393-403.
47. Reed SG: TGF-β in infections and infectious diseases. Microbes Infect 1999;1:1313-1325.
48. Roes J, Choi BK, and Cazac BB: Redirection of B cell responsiveness by transforming growth factor β receptor. Proc Natl Acad Sci USA 2003;100:7241-7246.
49. 1 to S transition, but not activation of human B lymphocytes. Exp Cell Res 1987;171:213-222.
50. Takeuchi M, Alard P, and Streilein JW: TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol 1998;160:1589-1597.
51. Tsunawaki S, Sporn M, Ding A, and Nathan C: Deactivation of macrophages by transforming growth factor-β. Nature 1988;334:260-262.
52. Turner M, Chantry D, and Feldmann M: Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine 1990;2:211-216.
53. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, and Stockinger B: TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-189.
54. Vodovotz Y, Bogdan C, Paik J, Xie QW, and Nathan C: Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med 1993;178:605-613.
55. Wahl SM, Allen JB, Weeks BS, Wong HL, and Klotman PE: Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 1993;90:4577-4581.
56. Wahl SM, Hunt DA, Wakefield L, McCartney-Francis N, Wahl LM, Roberts AB, and Sporn MB: Transforming growth factor β (TGF-β) induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:5788-5792.
57. Wahl SM, Swisher J, McCartney-Francis N, and Chen W: TGF-β: The perpetrator of immune suppression by regulatory T cells and suicidal T cells. J Leukoc Biol 2004;76: 15-24.
58. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 2005;23:287-296.
59. 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem 2000;275:36653-36658.
60. Williams AE, Humphreys IR, Cornere M, Edwards L, Rae A, and Hussell T: TGF-β prevents eosinophilic lung disease but impairs pathogen clearance. Microbes Infect 2005;7:365-374.
61. Wiseman DM, Polverini PJ, Kamp DW, and Leibovich SJ: Transforming growth factor-β (TGF-β) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 1988;157: 793-800.